Medical Health & Life Science Research News

Latin America point-of-care diagnostics industry size to touch $3.59 billion by 2021 according to new research report

Latin America point-of-care diagnostics industry size to touch $3.59 billion by 2021 according to new research report

Latin America Point-Of-Care Diagnostics Industry to reach $3.59 billion by 2021 with a CAGR of 9.68% | Market Data Forecast

- Advertising -

According to the report Latin America Point-Of-Care Diagnostics Industry, published by Market Data Forecast, The Industry was worth $2.26 billion in 2016 and estimated to reach $3.59 billion by the end of 2021 with a CAGR of 9.68%.

Point-of-care diagnostics allow a speedy, convenient, and cost-efficient way to diagnose diseases at healthcare centers and hospitals. Point-of-care diagnostics is a term collectively used for diagnostic procedures and tests performed on-site.

As compared to conventional in-laboratory tests, point-of-care diagnostics have the advantage of speed and convenience without compromising on consistency.

- Advertising -

The speed factor, especially, is the greatest attribute of point-of-care diagnostics, because faster diagnosis facilitates faster patient management. Point-of-care diagnostics help cut down on the need for sophisticated diagnostic systems for regular tests like blood tests and urine tests.

Browse Market data tables and in-depth TOC of the Latin America Point-Of-Care Diagnostics Industry to 2021 at www.marketdataforecast.com/market-…tics-market-1563/

Clinics and other healthcare establishments, in order to provide effective and fast diagnostic results, are opting for point-of-care test, which are consequently influencing industrial growth. Moreover, rising levels of patient awareness are expected to play a key role behind growth on account of the fact that patients, particularly the ones suffering from long-term diseases such as diabetes, are actively participating in the shift relating to the implementation of point-of-care diagnostic practices.

Additionally, healthcare practitioners have been observed to be increasingly more open and willing to adopt the use of point-of-care diagnostic consumables and medical devices thereby resulting in rapid demand and growth of this Industry. However, there are some certain Industry restraints that players need to overcome.

Reluctance from the industry towards changing the existing norms, frequent product recalls, stringent regulatory framework and unfavorable reimbursement scenario are some of the challenges faced by the point-of-care diagnostics Industry.

 

www.marketdataforecast.com/market-…63/request-sample

The Latin America point-of-care diagnostics Industry is segmented based on products, end-users and mode of delivery. Products have been segmented into Infectious Diseases, Cardiac Markers, Oncology Markers, OTC Diagnostic Tests, drugs of abuse, Blood Gas Testing, Fertility Testing, Urinalysis, Coagulation, Hematology, Glucose Monitoring, Ambulatory Chemistry, Decentralized Clinical Chemistry and others.

By End-Users, the Industry has been further segmented as clinics, hospitals, home healthcare, ambulatory care settings, laboratories and others. Finally on the basis of delivery, the Industry has been segmented further into OTC and prescription modes of delivery.

On the basis of geography, the Latin America Industry is analyzed under various regions namely Argentina, Brazil, and Mexico.  Emerging Industrys such as Brazil offer high growth potential for companies involved in the development and distribution of point-of-care diagnostic devices.

Increasing initiatives by Industry players, growing patient population base, and rise in the number of partnerships and joint ventures among point-of-care providers are the key factors driving the growth of point-of-care diagnostics Industry in emerging countries.

Some of the major players in this Industry are Abbott Laboratories, Inc., Danaher Corporation, Roche Diagnostics Limited, BioMerieux, Siemens Healthcare, Beckman Coulter, Inc., Becton, Dickinson and Company, Johnson & Johnson , Alere Inc., and PTS Diagnostics.

Report: www.marketdataforecast.com/market-…rket-1563/inquire

Key Points from Table of Contents

Overview                      

  • Executive Summary
  • Key Inferences         
  • Epidemology             

Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                      

Latin America Point-Of-Care Diagnostics Industry Segmentation                              

  • Product        
  • End-Users   
  • Mode of Delivery     

Geographical Analysis                                                                                       

  • Brazil                             
  • Mexico                         
  • Rest of Latin America                           

Strategic Analysis                        

  • PESTLE analysis         
  • Porter’s Five analysis              

Industry Leaders' Analysis                          

Competitive Landscape                            

www.marketdataforecast.com/market-…/request-discount

 

News From

Market Data Forecast - market research, business intelligence and consultingMarket Data Forecast
Category: Market Research Publishers and RetailersCompany profile: Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extens ...